317 related articles for article (PubMed ID: 15743195)
21. Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
Oishi S; Karki RG; Kang SU; Wang X; Worthy KM; Bindu LK; Nicklaus MC; Fisher RJ; Burke TR
J Med Chem; 2005 Feb; 48(3):764-72. PubMed ID: 15689160
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of peptide molecular recognition by phospholipase C gamma-1 Src homology-2 domain and a mutant Tyr phosphatase PTP1bC215S.
MacLean D; Sefler AM; Zhu G; Decker SJ; Saltiel AR; Singh J; McNamara D; Dobrusin EM; Sawyer TK
Protein Sci; 1995 Jan; 4(1):13-20. PubMed ID: 7773170
[TBL] [Abstract][Full Text] [Related]
23. Spatial constraints on the recognition of phosphoproteins by the tandem SH2 domains of the phosphatase SH-PTP2.
Eck MJ; Pluskey S; Trüb T; Harrison SC; Shoelson SE
Nature; 1996 Jan; 379(6562):277-80. PubMed ID: 8538796
[TBL] [Abstract][Full Text] [Related]
24. Identification of natural ligands for SH2 domains from a phage display cDNA library.
Cochrane D; Webster C; Masih G; McCafferty J
J Mol Biol; 2000 Mar; 297(1):89-97. PubMed ID: 10704309
[TBL] [Abstract][Full Text] [Related]
25. Epitope mapping of SHP-1 monoclonal antibodies using peptide phage display.
Murthy KK; Shen SH; Banville D
Biochem Biophys Res Commun; 1998 Jul; 248(1):69-74. PubMed ID: 9675087
[TBL] [Abstract][Full Text] [Related]
26. Mutational investigation of the specificity determining region of the Src SH2 domain.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
[TBL] [Abstract][Full Text] [Related]
27. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.
Nam NH; Ye G; Sun G; Parang K
J Med Chem; 2004 Jun; 47(12):3131-41. PubMed ID: 15163193
[TBL] [Abstract][Full Text] [Related]
28. Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1).
Ettmayer P; France D; Gounarides J; Jarosinski M; Martin MS; Rondeau JM; Sabio M; Topiol S; Weidmann B; Zurini M; Bair KW
J Med Chem; 1999 Mar; 42(6):971-80. PubMed ID: 10090780
[TBL] [Abstract][Full Text] [Related]
29. A repertoire library that allows the selection of synthetic SH2s with altered binding specificities.
Malabarba MG; Milia E; Faretta M; Zamponi R; Pelicci PG; Di Fiore PP
Oncogene; 2001 Aug; 20(37):5186-94. PubMed ID: 11526507
[TBL] [Abstract][Full Text] [Related]
30. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
Poole AW; Jones ML
Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691
[TBL] [Abstract][Full Text] [Related]
31. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP
J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402
[TBL] [Abstract][Full Text] [Related]
32. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
Bradshaw JM; Mitaxov V; Waksman G
J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
[TBL] [Abstract][Full Text] [Related]
33. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
[TBL] [Abstract][Full Text] [Related]
34. Identification of non-phosphate-containing small molecular weight inhibitors of the tyrosine kinase p56 Lck SH2 domain via in silico screening against the pY + 3 binding site.
Huang N; Nagarsekar A; Xia G; Hayashi J; MacKerell AD
J Med Chem; 2004 Jul; 47(14):3502-11. PubMed ID: 15214778
[TBL] [Abstract][Full Text] [Related]
35. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2.
Jackson DE; Kupcho KR; Newman PJ
J Biol Chem; 1997 Oct; 272(40):24868-75. PubMed ID: 9312087
[TBL] [Abstract][Full Text] [Related]
36. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
Bradshaw JM; Grucza RA; Ladbury JE; Waksman G
Biochemistry; 1998 Jun; 37(25):9083-90. PubMed ID: 9636054
[TBL] [Abstract][Full Text] [Related]
37. Tyr66 acts as a conformational switch in the closed-to-open transition of the SHP-2 N-SH2-domain phosphotyrosine-peptide binding cleft.
Guvench O; Qu CK; MacKerell AD
BMC Struct Biol; 2007 Mar; 7():14. PubMed ID: 17378938
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
[TBL] [Abstract][Full Text] [Related]
39. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin.
Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ
Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578
[TBL] [Abstract][Full Text] [Related]
40. Direct determination of the sequence recognition requirements of the SH2 domains of SH-PTP2.
Huyer G; Li ZM; Adam M; Huckle WR; Ramachandran C
Biochemistry; 1995 Jan; 34(3):1040-9. PubMed ID: 7530043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
